Menlo Park, CA, United States of America

Atheromed, Inc.


USPTO Granted Patents = 29

% Expired Patents = 6.9


Trademarks = 2

Forward Citations = 2,810

Loading Chart...
Loading Chart...

9 inventors (with patents filed for the assignee):

goldMedal Christopher James Danek (28 out of 87 patents)

silverMedal John T To (28 out of 142 patents)

bronzeMedal Paul Quentin Escudero (19 out of 36 patents)

4.  August Christopher Pombo (10 out of 13 patents)

5.  Torrey Smith (10 out of 18 patents)

6.  Douglas E Rowe (5 out of 11 patents)

7.  Brenda Hann (5 out of 5 patents)

8.  Uriel Hiram Chee (4 out of 25 patents)

9.  Uriel Hiran Chee (1 out of 1 patent)

10.  Hiram Chee (2 patents)

11.  John T To (11 patents)

12.  Paul Escudero (0 patent)

13.  John To (0 patent)

14.  Christopher J Danek (0 patent)


Core Competencies:
Atherectomy
Occlusive Material
Debulking
Blood Vessel
Bioactive Material
Device Systems
Apparatus Methods
Restenosis

29 patents:

Atheromed, Inc. is a biotechnology company based in Menlo Park, California, focused on developing innovative solutions for cardiovascular diseases. The company specializes in advanced medical devices aimed at improving the treatment of atherosclerosis, a condition characterized by the buildup of plaque in arteries. Atheromed's research emphasizes the integration of cutting-edge technology with clinical applications, striving to enhance patient outcomes through minimally invasive procedures and targeted therapies.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

29 Patents

#57 in Menlo Park, CA

#2,766 in California

#11,615 in US

#22,530 in the World

Menlo Park, CA (US)
Menlo Park, CA, United States of America
Forward Citations = 2,810

9 inventors:

Please report any incorrect information to [email protected]
Loading…